Quarterly report · Q3
2796.TEDINET S100QKFA
Period2022-06-01 → 2023-02-28
Filed2023-04-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥38.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥51.6bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.6bn | 2021-06-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥896m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2021-06-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥890m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥722m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥967m | 2021-06-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥208m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥447m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥322m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥218m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥326m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥22.9bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥23.7bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥23.8bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.1bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥17.0bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.8bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥22.24 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.45 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.99 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.6 | 2021-06-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.68 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥16.89 | 2022-06-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.29 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.16 | 2021-06-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.4% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.9% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2023-02-28 | ¥37m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥226m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥170m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥56m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥70m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-02-28 | ¥560m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-02-28 | ¥560m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-02-28 | ¥22m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-02-28 | −¥235m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥5.7bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥5.7bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2021-06-01 → 2022-02-28 | −¥151m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥516m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥516m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥71m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥31.4bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥31.4bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥1.2bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥377m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥377m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥48m |
| —segment total | revenue | 2021-06-01 → 2022-02-28 | ¥38.0bn |
| —segment total | revenue external | 2021-06-01 → 2022-02-28 | ¥38.0bn |
| —segment total | segment profit | 2021-06-01 → 2022-02-28 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-02-28 | ¥38.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-02-28 | ¥38.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-02-28 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 387
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 38018000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 560000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 38579000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 38579000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | 1244000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | -151000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 71000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | 48000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1213000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 22000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1236000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -235000000 | JPY |
| Operating income | Prior1YTDDuration | 1000000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | 31532000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | 5760000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 485000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | 378000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 38156000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 573000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 38730000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 38730000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | 31532000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | 5760000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 485000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | 378000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 38156000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 573000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 38730000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 38730000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | 1129000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | -170000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 56000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | 70000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1086000000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 37000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1123000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -226000000 | JPY |
| Operating income | CurrentYTDDuration | 896000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |